Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Andrew Stewart
Court of Appeals resolves Appellate Division split and explains when a statute is “sufficiently specific” in order to establish vicarious liability under New York’s Labor Law
June 1, 2026 To embed, copy and paste the code into your website or blog: Last week, the Court of Appeals decided whether the statutory language of Industrial Code Section 23-4.2(k) was “sufficiently specific” to impose vicarious liability against a construction site owner under Labor Law § 241(6). SeeMann v. Mezuyon, LLC, et al., 2026 WL 1462931, 2026 N.Y. Slip. Op. 03257 (N.Y. May 26, 2026).
What duty of care is owed by a hotel to a suicidal guest? The Court of Appeals examines the “assumption of duty” doctrine and enters judgment in favor of NYC hotel
Last month, the Court of Appeals explored the issue of the applicable duty of care owed by a hotel to a suicidal guest. In Beadell v. Eros Mgmt. Realty LLC, No. 11, 2026 WL 466787 (N.Y. Feb. 19, 2026), the Court of Appeals affirmed the Appellate Division’s entry of summary judgment, holding that the hotel satisfied its duty of care owed to the guest’s family members who had reported concerns about the guest’s suicidal ideations.
Case Study: how Product Hunt can improve AI visibility in 2026
by Featured•3d ago Product Hunt is best known for its homepage, a daily leaderboard of the most creative and innovative products on the internet. Makers go all out to win launch day, because that visibility matters. Product Hunt also plays a significant role in how products appear in Google search results. What surprised us was that AI assistants like ChatGPT were rarely citing Product Hunt in product recommendations.
What constitutes a “Client File”? The Southern District of New York reiterates the “entire file” approach for returning files to a former client | JD Supra
September 26, 2025 To embed, copy and paste the code into your website or blog: The entire file standard was first adopted by the Court of Appeals of New York in 1997 in the matter of Sage Realty Corp. v. Proskauer Rose Goetz & Mendelsohn L.L.P., 91 N.Y.2d 30, 36-38 (1997). In that matter, the Court of Appeals weighed the “entire file” approach vs. the “end product” approach to determine which was the more appropriate standard for defining the client’s file. Sage Realty Corp., 91 N.Y.2d at 34-37.
When is an injured worker’s own conduct a defense to liability under New York’s Scaffold Law? | JD Supra
In a recently published opinion, the Appellate Division, Second Department, upheld a Suffolk County Supreme Court decision granting summary judgment in favor of an injured bridge worker who slipped backwards off a scaffold while sandblasting the side of a bridge and fell 20 feet.
Nasdaq Increases Initial Listing Liquidity Requirements: What It Means for Companies Going Public | JD Supra
On March 12, 2025, the SEC approved a significant rule change to Nasdaq’s initial listing liquidity requirements (the New Liquidity Rules). These changes make it more challenging for companies seeking to list on the Nasdaq Global Market or Nasdaq Capital Market. However, they do not impact already public companies trading on the OTC market (including Canadian and other foreign public companies) that meet Nasdaq’s trading volume requirements.
Continued Investment in AI Drug Discovery Points to Potential Future Significance of Inventorship in Biosimilar Litigation | JD Supra
On December 3, 2024, Bristol Myers Squibb announced a collaboration agreement with three-year-old startup AI Proteins.[1] According to its founder, Chris Bahl, PhD, AI Proteins uses “AI, synthetic biology, and laboratory automation to rapidly design and optimize novel miniproteins with ideal drug-like properties.”[2] The end goal of this collaboration is likely biologic products incorporating AI-generated proteins.
Can Chat-GPT Be My Co-Counsel? The Rise of AI and Its Implication on the Attorney-Client Relationship | JD Supra
We are halfway through 2024 and one thing is clear: the “AI” marketing is booming. Nvidia, the software company dubbed the “artificial intelligence titan,” has a market cap of over $3 trillion and recently issued a 10-for-1 stock split.[1] AI apps, such as ChatGPT, are just a click away, and will soon be available via simple voice commands on your iPhone.[2] But what does easy, seemingly unlimited access to AI mean for the practicing attorney?
Pay No Attention to that Man Behind the Curtain: Federal Regulators Crack Down on AI Washing | JD Supra
After more than a decade of development, Amazon has pulled the plug on its “Just Walk Out” technology where Amazon would use artificial intelligence (AI) and machine learning to analyze footage from in-store cameras to calculate your bill.[1] The pitch was intriguing: walk into a store, take what you need off the shelf, and “Just Walk Out.”[2]. The reality ended up being just as intriguing, but for a much different reason: humans operators were instead reviewing the transactions.
The Pros And Cons Of Protecting AI As Trade Secrets | JD Supra
Trade secrets have become a de facto intellectual property right for securing valuable artificial intelligence information. Despite regulatory trends toward greater transparency of AI models, federal policy acknowledges, and perhaps endorses, trade secret protection for AI information.
Statutes of Limitations vs. Statutes of Repose. What Are They, and How Do They Affect Contractors and Design Professionals in Maryland? | JD Supra
Statutes of limitations and statutes of repose, when applicable, can provide time-based defenses that will bar a complaint filed against contractors and design professionals, whether the claim is based in contract or in negligence. Generally speaking, the time limitations for bringing claims established by statutes of limitations operate within the time limit on bringing claims established by statutes of repose. Statutes of limitations run from the date the cause of action accrues.
New BPCIA Case Filed: Genentech and Biogen Want to Stop Dr. Reddy’s Rituximab Biosimilar from Entering the U.S. Market | JD Supra
December 4, 2023 To embed, copy and paste the code into your website or blog: On November 17, 2023, Genentech, Hoffman-La Roche, and Biogen (collectively “plaintiffs”) filed a complaint in the federal district court for the District of New Jersey against Dr. Reddy’s Laboratories and Fresenius Kabi (collectively “defendants”) (DNJ No. 23-cv-22485).
New BPCIA Case Filed: Genentech and Biogen Want to Stop Dr. Reddy’s Rituximab Biosimilar from Entering the U.S. Market
On November 17, 2023, Genentech, Hoffman-La Roche, and Biogen (collectively “plaintiffs”) filed a complaint in the federal district court for the District of New Jersey against Dr. Reddy’s Laboratories and Fresenius Kabi (collectively “defendants”) (DNJ No. 23-cv-22485). The plaintiffs allege that the defendants infringe or intend to infringe fifteen patents related to the biologic rituximab, which the plaintiffs sell as Rituxan.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Andrew
Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack